Our Healthcare Hot Topics of the Week

Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:

1) Amgen, Novartis aim for big, crowded migraine market after new drug data. Reuters, November 17, 2016.

Fewer debilitating headaches were reported after trial participants used the drug erenumab.

2) Walgreens Claims Theranos Voided 11.3% of Test Reports. The Wall Street Journal, November 15, 2016.

Theranos Inc. allegedly voided some blood-test reports that the firm provided to customers of Walgreens stores.

3) Ex-sleuths sue GlaxoSmithKline over imprisonment in China. Reuters, November 16, 2016.

Two former corporate investigators sued the drugmaker saying the company misled them resulting in their imprisonment.

4) Patients May Still Get a ‘Surprise’ Bill After an In-Network ER Visit, Study Finds. The Wall Street Journal, November 16, 2016.

Patients who get in-network emergency care have a 1 in 4 chance of being treated by an out-of-network physician.

5) Obamacare Startup Oscar Has $45 Million Loss in Three States. Bloomberg, November 15, 2016.

Oscar Insurance Corp. has continued to lose money on the federal health exchange.

Do you have questions about healthcare issues? We can help. For assistanceCLICK HERE.

Get “News You Can Use” delivered directly to your e-mail inbox. CLICK HERE TO SUBSCRIBE.

P.S. If you or your patients are interested in consumer healthcare issues, check out myhealthspin.com.

Related Posts


Recent Posts

Do Cyberattacks Increase Mortality?
October 4, 2022
When Should I Have an Estate Plan?
September 29, 2022
The Dangers of Unpatched Medical Devices
September 27, 2022
Michigan: What Happens to Your Assets When You Don’t Have an Estate Plan?
September 22, 2022
Is Cancer on the Rise?
September 20, 2022


Enter your email to subscribe now and receive your FREE HIPAA Risk Assessment book!

An essential tool for all healthcare providers, Easy Guide to HIPAA Risk Assessments breaks down the requirements of HIPAA so you can successfully complete your required risk assessment.


Get it now for FREE (an $8.99 value!)

One more step! Please check your email to confirm your subscription and receive your FREE book!